Top Tweets for #XTANDI
ESMO 2025 GU malignancy Late Abstracts https://t.co/rFvwQaqY8u
@OSUCCC_James @OSU_Urology @OhioStateMedOnc @myESMO @OSUWexMed @ASCO
#ESMO2025
#GUCancer
#ProstateCancer
#KidneyCancer
#BladderCancer
#Oncology
#CancerResearch
#Enzalutamide
#Xtandi
#MedicalEducation
#OncTwitter
Ontario is the first province to expand #XTANDI® access for men with #ProstateCancer, enabling timely treatment when it matters most.
Ontario is breaking down barriers to faster #CancerCare and the province’s upcoming pilot will connect patients to life-saving medicines sooner.
Bernie was right. The Prostate President Joe Biden doomed thousands of men with prostate cancer to death because they couldn’t afford #Xtandi, which Pfizer is gouging for > $15,000 per monthly supply.
The Trump Administration can break this patent and save thousands of lives
I am extremely disappointed that the Biden Administration denied a petition to reduce the price of Xtandi.
As HELP Committee chairman, I will do everything I can to take make sure that drugs that are developed with U.S. taxpayer money are sold here at a reasonable price.
💫🌟#Pfizer’s #TALZENNA® in Combination with #XTANDI® Prolongs Overall Survival in Phase 3 #TALAPRO-2 Trial 🧬
@OncoAlert
1️⃣ TALAPRO-2 Trial 🔬: First and only PARP inhibitor (TALZENNA) + ARPI (XTANDI) combo to significantly improve overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC).
2️⃣ Statistically significant OS benefit 📈 in both all-comers and HRR-mutated mCRPC patients.
3️⃣ Potential label update: Positive results will be shared with global health authorities 🌍 to potentially expand TALZENNA’s approved indications.
4️⃣ Hope for patients 🫂: Metastatic castration-resistant prostate cancer is one of the most aggressive stages, and this combination provides new hope for patients in need of effective treatments.
5️⃣ Next steps 🔜: Results to be presented at an upcoming medical congress, marking a potential shift in the treatment landscape for mCRPC.
#CancerResearch #ProstateCancer #Oncology #mCRPC #TALZENNA #XTANDI #ClinicalTrials #Breakthroughs
https://t.co/BHUANYAQKf
🔬💊#Pfizer ( $PFE) reporta avances en el tratamiento del cáncer de próstata avanzado. La combinación de #Talzenna y #Xtandi mejora la supervivencia en pacientes con cáncer. ¿Será este un nuevo estándar en oncología? 🧬📈 #Ciencia #Inversiones
$PFE patent expiration of #Xtandi #enzalutamide in 2027, this may make $EPIX more of a target to extend that program and not share this time w/ Astellas for next gen combo w/ $EPIX #masofaniten for prostate cancer. $10B/yr market
Big Sunday night activism scoop: Starboard Value has a stake of roughly $1 billion in Pfizer and is pushing the struggling drugmaker to turn its performance around. $PFE
https://t.co/57pM2fKNfJ
$EPIX #masofaniten combo studies w/ Astellas / $PFE #xtandi, $JNJ #Eleada, and Bayer #Nubeqa. Exciting to see how much better this combo will be over current therapies.
So far in Ph1 maso+ #enzalutamide 88% patients achieved PSA90! After 15m median progression still not seen!
J&J's Erleada prevails over Astellas, Pfizer’s Xtandi in real-world prostate cancer study https://t.co/7qCpjBCOsv
@AstellasUS' Enzalutamide (#XTANDI) granted European Commission approval for use in additional recurrent early #ProstateCancer treatment setting. Approval based on results of the #EMBARK study. #ReadNow details on UroToday > https://t.co/S4tRbVandx
Astellas CStO Pearson: We’re Not Short Of Opportunities To Compensate For LOEs. Astellas’ chief strategy officer, Adam Pearson, talks to Scrip about the company’s launch execution thrust for key therapies ahead of...
Related... https://t.co/MjwNsB28b4 #PharmaScrip
Promising clinical results announced from a relative bioavailability study of nanocrystalline-enabled enzalutamide, an alternative to the amorphous solid dispersion (ASD) used in Xtandi®️!
#xtandi #enzalutamide #prostatecancer #smallispowerful
https://t.co/6xkOdgaG24
@NanoformF Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide
https://t.co/Kxps5mwNJq Contact @ChristianDJones to discuss live at @jpmorgan Healthcare Conference next week. [email protected]
#enzalutamide #xtandi #patientcentricity
Astellas $ALPMY continue acquisition trend and further strengthens its #prostatecancer platform.
#XTANDI #enzalutamide is currently 44% of Astellas sales and goes OFF patent in 2027.
$EPIX P1 combo therapy of its #Masofaniten w/ enza shows #PSA90 more than double enza alone
$EPIX this earlier post of mine even more significant in light of data from #ESMO23 for EPI-7386 in combo with #Xtandi #enzalutamide and its 90% PSA90 response rate.
#Xtandi is 44% of #Astellas sales, off patent in 2027.
I would think $EPIX is worth several billion to Astellas.
After today's $ICPT who is next. Astellas will have to revitalise it's pipeline by 2027, its combo drug trial with $EPIX is a prime candidate.
Maybe others are picking up on this as $EPIX up 6.5% and rising into close.
Key data to be released at #ESMO23 at end of Oct.
$EPIX even better than I thought:
#ESMO23 poster shows EPI-7386 w/ #enzalutamide achieved 90% PSA90, that is 3-4x better than #Xtandi alone in mCRPC.
Note Phase 3 Xtandi trial in mCRPC patients receiving prior chemotherapy, the PSA90 was just 25% at 12 mo.
#Astellas
@BehaviorFin I just posted the PSA90 data from #ESMO23 abstract for $EPIX: 90% v 47% for #enzalutamide (#Xtandi) alone.
A huge thank you to our Platinum Level Partners, @AstellasUS and @PfizerOncMed, as well as Dr. Paul Sieber for providing us with up-to-date guidelines and very educational overview for mCSPC #Xtandi #FUS2023
#CoffeeCan Portfolio Update:
$LIO $LIO.V $LOMLF $PEX $PEX.V $PEXZF $CRVS $EPIX
4 year charts w/ avg purchase price blue line
Catalysts end of year
$LIO 1st commercial gold
$PEX Potential to find feeder at Kliyul
$CRVS FDA Phase 3 meeting
$EPIX Combo study w/ #Xtandi results
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.6M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
110.6M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.7M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
90.9M followers
KATY PERRY
@katyperry
87.7M followers
Taylor Swift
@taylorswift13
81.5M followers
Lady Gaga
@ladygaga
73.1M followers
Virat Kohli
@imvkohli
69.9M followers
Kim Kardashian
@kimkardashian
69.8M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
63.9M followers
Neymar Jr
@neymarjr
62.7M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
X
@x
60.8M followers
Selena Gomez
@selenagomez
60.8M followers